COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 1522: Articles 15211-15220  | Next

Metformin Is Associated with Favorable Outcomes in Patients with COVID-19 and Type 2 Diabetes Mellitus
Ma, Z., Patel, N., Vemparala, P., Krishnamurthy, M.
10.1101/2021.05.20.21257490 — Posted: 2021-05-21
SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environments
Rife Magalis, B., Mavian, C., Tagliamonte, M., Rich, S., Cash, M., Riva, A., Loeb, J. C., Norris, M., Moraga, D., Zhang, Y., Shapiro, J., Starostik, P., Marini, S., Myers, P., Ostrov, D. A., Lednicky, J. A., Morris, J. G., Lauzardo, M., Salemi, M.
10.1101/2021.05.19.21257237 — Posted: 2021-05-21
A cross-sectional study of the mismatch between telecommuting preference and frequency associated with psychological distress among Japanese workers in the COVID-19 pandemic
Otsuka, S., Ishimaru, T., Nagata, M., Tateishi, S., Eguchi, H., Tsuji, M., Ogami, A., Matsuda, S., Fujino, Y.
10.1101/2021.05.20.21257516 — Posted: 2021-05-21
AnmO2l: An open-source pulse-dose oxygen conserving device for the COVID-19 crisis
Li, H., Krishnamurthy, D., Kothari, A., Li, E., Lipnick, M., Gaba, D., Fanning, R. M., Prakash, M.
10.1101/2021.05.19.21257477 — Posted: 2021-05-21
Epidemiological characteristics of three SARS-CoV-2 variants of concern and implications for future COVID-19 pandemic outcomes
Yang, W., Shaman, J.
10.1101/2021.05.19.21257476 — Posted: 2021-05-21
Covid19 Pandemic Policy Monitor (COV-PPM): European level tracking of non-pharmaceutical interventions
Bozorgmehr, K., Rohleder, S., Duwendag, S. L., Mohsenpour, A. M., Saint, V., Gold, A. W., Kaur, S., Nutsch, N., Costa, D.
10.1101/2021.05.20.21257507 — Posted: 2021-05-21
Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports
Shapiro, J., Dean, N. E., Madewell, Z. J., Yang, Y., Halloran, M. E., Longini, I. M.
10.1101/2021.05.20.21257461 — Posted: 2021-05-21
Early Detection of COVID-19 Outbreaks Using Human Mobility Data
Guan, G., Dery, Y., Yechezkel, M., Ben-Gal, I., Yamin, D., Brandeau, M.
10.1101/2021.05.20.21257557 — Posted: 2021-05-21
Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: Randomized controlled trial
Elgohary, M. A.-S., Hasan, E. M., Ibrahim, A. A., Ahmed, M. F., Abdel-Rahman, R. Z., Zaki, A. I., Elaatar, M. B., Elnagar, M. T., Emam, M. E., Hamada, M. M., Abdel-Hamid, T. M., Abdel-Hafez, A. S., Seadawy, M. G., Fatoh, A. R., Elsaied, M. A., Sakr, M. A.-R., Elkady, A. O., Shehata, M. M., Nawar, O. M., Selem, M. A.-e., Abd-aal, M. S., Lotfy, H. H., Elnagdy, T. R., Helmy, S., Mubark, M. A.
10.1101/2021.05.19.21257429 — Posted: 2021-05-21 Discussion: Onsite
Demographic disparities in clinical outcomes of COVID-19: data from a statewide cohort in South Carolina
YANG, X., Zhang, J., Chen, S., Bruner, L., Diedhiou, A., Scott, C., Mansaray, A., Weissman, S., Li, X.
10.1101/2021.05.19.21257489 — Posted: 2021-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).